Publication | Closed Access

Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice

Tumor ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseMedicineImmunologyTumor ImmunityTherapeutic VaccineAntigen ProcessingAutoimmunityCtl ResponsesCd4 T Cell ResponsesImmunotherapyHla-a2/her2 MiceCell BiologyTransgenic FvbneunTumor Microenvironment